- Home
- AUTL vs LFMD Comparison
AUTL vs LFMD Comparison
Compare AUTL & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- LFMD
- Stock Information
- Founded
- AUTL 2014
- LFMD 1994
- Country
- AUTL United Kingdom
- LFMD United States
- Employees
- AUTL N/A
- LFMD N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- LFMD Medical/Nursing Services
- Sector
- AUTL Health Care
- LFMD Health Care
- Exchange
- AUTL Nasdaq
- LFMD Nasdaq
- Market Cap
- AUTL 625.4M
- LFMD 535.4M
- IPO Year
- AUTL 2018
- LFMD N/A
- Fundamental
- Price
- AUTL $2.40
- LFMD $10.41
- Analyst Decision
- AUTL Strong Buy
- LFMD Buy
- Analyst Count
- AUTL 5
- LFMD 6
- Target Price
- AUTL $9.32
- LFMD $12.50
- AVG Volume (30 Days)
- AUTL 1.6M
- LFMD 980.5K
- Earning Date
- AUTL 08-12-2025
- LFMD 08-11-2025
- Dividend Yield
- AUTL N/A
- LFMD N/A
- EPS Growth
- AUTL N/A
- LFMD N/A
- EPS
- AUTL N/A
- LFMD N/A
- Revenue
- AUTL $9,011,000.00
- LFMD $234,007,330.00
- Revenue This Year
- AUTL $472.28
- LFMD $29.80
- Revenue Next Year
- AUTL $114.92
- LFMD $18.03
- P/E Ratio
- AUTL N/A
- LFMD N/A
- Revenue Growth
- AUTL N/A
- LFMD 43.07
- 52 Week Low
- AUTL $1.11
- LFMD $3.99
- 52 Week High
- AUTL $5.00
- LFMD $15.84
- Technical
- Relative Strength Index (RSI)
- AUTL 50.28
- LFMD 40.01
- Support Level
- AUTL $2.33
- LFMD $9.95
- Resistance Level
- AUTL $2.60
- LFMD $10.98
- Average True Range (ATR)
- AUTL 0.16
- LFMD 0.55
- MACD
- AUTL -0.03
- LFMD -0.08
- Stochastic Oscillator
- AUTL 18.92
- LFMD 28.22
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About LFMD LifeMD Inc.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.